|
It was reported that a patient underwent an unknown procedure on (b)(6), 2021 and suture was used.During the procedure, the surgeon attempted to bend the needle and the needle broke.Both halves of the needle recovered.No adverse patient consequences were reported.Additional information was requested.
|
|
Product complaint # (b)(4).Date sent to the fda: 02/09/2022.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc., or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H3 evaluation: a failed suture needle, labeled as (b)(4), was submitted to fractographic evaluation.The component was identified as product code j269h.It was requested that assess the fracture mode of the failure.A fracture was observed in the body of the needle.One side of the needle was received, the mating fracture surface was not provided for this evaluation.A scanning electron microscope was used to examine the fracture surfaces and surrounding area of the needle.The fracture surfaces were examined in multiple locations to determine the fracture mode.The evaluation of (b)(4) revealed the fracture was composed of microvoid coalescence, which is evidence of a ductile fracture mode.This was a ductile fracture.The evidence of this examination indicates that the breakage occurred from mechanical deformation, indents and scratches, due to gripping, bending and overstressing of the needle. there is no evidence of any material flaw that would cause premature failure.The needle breakage was confirmed.
|